Cardiff Oncology Stock Price History
CRDF Stock | USD 2.61 0.07 2.76% |
Below is the normalized historical share price chart for Cardiff Oncology extending back to July 27, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cardiff Oncology stands at 2.61, as last reported on the 1st of December, with the highest price reaching 2.69 and the lowest price hitting 2.57 during the day.
If you're considering investing in Cardiff Stock, it is important to understand the factors that can impact its price. Cardiff Oncology appears to be very risky, given 3 months investment horizon. Cardiff Oncology secures Sharpe Ratio (or Efficiency) of 0.0773, which signifies that the company had a 0.0773% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Cardiff Oncology, which you can use to evaluate the volatility of the firm. Please makes use of Cardiff Oncology's Risk Adjusted Performance of 0.0577, mean deviation of 3.82, and Downside Deviation of 7.32 to double-check if our risk estimates are consistent with your expectations.
At this time, Cardiff Oncology's Common Stock Total Equity is most likely to increase significantly in the upcoming years. The Cardiff Oncology's current Preferred Stock Total Equity is estimated to increase to 1,208, while Liabilities And Stockholders Equity is projected to decrease to roughly 45.3 M. . At this time, Cardiff Oncology's Price To Sales Ratio is most likely to increase significantly in the upcoming years. The Cardiff Oncology's current Price Sales Ratio is estimated to increase to 201.15, while Price Earnings Ratio is projected to decrease to (1.68). Cardiff Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of July 2004 | 200 Day MA 3.1149 | 50 Day MA 2.83 | Beta 1.928 |
Cardiff |
Sharpe Ratio = 0.0773
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | CRDF | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.74 actual daily | 51 51% of assets are less volatile |
Expected Return
0.44 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Cardiff Oncology is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cardiff Oncology by adding it to a well-diversified portfolio.
Price Book 2.702 | Enterprise Value Ebitda (3.66) | Price Sales 193.981 | Shares Float 47.8 M | Wall Street Target Price 9.1575 |
Cardiff Oncology Stock Price History Chart
There are several ways to analyze Cardiff Stock price data. The simplest method is using a basic Cardiff candlestick price chart, which shows Cardiff Oncology price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 7, 2024 | 4.09 |
Lowest Price | September 6, 2024 | 2.11 |
Cardiff Oncology December 1, 2024 Stock Price Synopsis
Various analyses of Cardiff Oncology's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cardiff Stock. It can be used to describe the percentage change in the price of Cardiff Oncology from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cardiff Stock.Cardiff Oncology Price Action Indicator | 0.01 | |
Cardiff Oncology Price Daily Balance Of Power | 0.58 | |
Cardiff Oncology Price Rate Of Daily Change | 1.03 |
Cardiff Oncology December 1, 2024 Stock Price Analysis
Cardiff Stock Price History Data
The price series of Cardiff Oncology for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 1.98 with a coefficient of variation of 14.39. The prices are distributed with arithmetic mean of 2.72. The median price for the last 90 days is 2.63. The company had 1:6 stock split on 20th of February 2019. Cardiff Oncology issued dividends on 2019-02-20.Open | High | Low | Close | Volume | ||
12/01/2024 | 2.58 | 2.69 | 2.57 | 2.61 | ||
11/29/2024 | 2.58 | 2.69 | 2.57 | 2.61 | 297,671 | |
11/27/2024 | 2.47 | 2.54 | 2.44 | 2.54 | 642,785 | |
11/26/2024 | 2.48 | 2.53 | 2.38 | 2.46 | 543,669 | |
11/25/2024 | 2.49 | 2.63 | 2.44 | 2.45 | 616,880 | |
11/22/2024 | 2.50 | 2.57 | 2.44 | 2.45 | 482,966 | |
11/21/2024 | 2.55 | 2.59 | 2.47 | 2.50 | 476,955 | |
11/20/2024 | 2.65 | 2.66 | 2.51 | 2.53 | 490,834 | |
11/19/2024 | 2.63 | 2.70 | 2.52 | 2.62 | 605,662 | |
11/18/2024 | 2.60 | 2.69 | 2.52 | 2.58 | 513,975 | |
11/15/2024 | 2.88 | 2.88 | 2.53 | 2.58 | 1,320,304 | |
11/14/2024 | 2.98 | 3.01 | 2.80 | 2.84 | 511,152 | |
11/13/2024 | 3.16 | 3.16 | 2.95 | 2.97 | 843,633 | |
11/12/2024 | 3.44 | 3.44 | 3.08 | 3.14 | 816,251 | |
11/11/2024 | 3.11 | 3.67 | 3.11 | 3.46 | 1,253,803 | |
11/08/2024 | 4.13 | 4.23 | 2.85 | 3.08 | 3,658,021 | |
11/07/2024 | 3.83 | 4.38 | 3.77 | 4.09 | 1,828,595 | |
11/06/2024 | 3.86 | 3.99 | 3.53 | 3.81 | 1,340,728 | |
11/05/2024 | 3.78 | 3.82 | 3.50 | 3.69 | 1,027,722 | |
11/04/2024 | 3.20 | 3.79 | 3.06 | 3.74 | 1,782,900 | |
11/01/2024 | 3.12 | 3.36 | 3.12 | 3.21 | 683,914 | |
10/31/2024 | 3.31 | 3.40 | 3.00 | 3.12 | 1,695,896 | |
10/30/2024 | 3.12 | 3.24 | 3.01 | 3.12 | 784,351 | |
10/29/2024 | 2.98 | 3.18 | 2.95 | 3.12 | 1,104,311 | |
10/28/2024 | 2.88 | 3.12 | 2.88 | 2.99 | 689,801 | |
10/25/2024 | 2.77 | 2.94 | 2.73 | 2.83 | 574,037 | |
10/24/2024 | 2.90 | 2.97 | 2.73 | 2.73 | 693,712 | |
10/23/2024 | 2.82 | 2.89 | 2.74 | 2.86 | 565,702 | |
10/22/2024 | 2.80 | 2.83 | 2.73 | 2.81 | 442,253 | |
10/21/2024 | 2.89 | 2.90 | 2.68 | 2.77 | 1,065,163 | |
10/18/2024 | 2.82 | 3.24 | 2.82 | 2.90 | 1,672,670 | |
10/17/2024 | 2.81 | 2.83 | 2.72 | 2.79 | 309,321 | |
10/16/2024 | 2.70 | 2.88 | 2.68 | 2.79 | 658,124 | |
10/15/2024 | 2.67 | 2.73 | 2.61 | 2.67 | 405,432 | |
10/14/2024 | 2.63 | 2.67 | 2.56 | 2.63 | 238,055 | |
10/11/2024 | 2.52 | 2.64 | 2.50 | 2.63 | 421,054 | |
10/10/2024 | 2.56 | 2.63 | 2.46 | 2.52 | 438,493 | |
10/09/2024 | 2.72 | 2.74 | 2.52 | 2.52 | 501,320 | |
10/08/2024 | 2.67 | 2.77 | 2.63 | 2.74 | 754,134 | |
10/07/2024 | 2.65 | 2.83 | 2.58 | 2.67 | 823,817 | |
10/04/2024 | 2.58 | 2.70 | 2.56 | 2.60 | 564,546 | |
10/03/2024 | 2.57 | 2.63 | 2.50 | 2.53 | 336,873 | |
10/02/2024 | 2.45 | 2.64 | 2.45 | 2.58 | 785,191 | |
10/01/2024 | 2.67 | 2.68 | 2.42 | 2.47 | 738,727 | |
09/30/2024 | 2.77 | 2.84 | 2.61 | 2.67 | 551,917 | |
09/27/2024 | 2.81 | 2.88 | 2.74 | 2.77 | 429,091 | |
09/26/2024 | 2.68 | 2.84 | 2.63 | 2.76 | 496,599 | |
09/25/2024 | 2.63 | 2.79 | 2.58 | 2.68 | 440,212 | |
09/24/2024 | 2.58 | 2.64 | 2.52 | 2.62 | 411,111 | |
09/23/2024 | 2.75 | 2.81 | 2.57 | 2.58 | 769,755 | |
09/20/2024 | 2.52 | 2.71 | 2.51 | 2.68 | 1,004,453 | |
09/19/2024 | 2.56 | 2.71 | 2.47 | 2.53 | 613,089 | |
09/18/2024 | 2.62 | 2.66 | 2.42 | 2.46 | 382,730 | |
09/17/2024 | 2.60 | 2.62 | 2.48 | 2.54 | 314,956 | |
09/16/2024 | 2.75 | 2.82 | 2.51 | 2.57 | 601,364 | |
09/13/2024 | 2.57 | 2.76 | 2.52 | 2.71 | 633,636 | |
09/12/2024 | 2.35 | 2.68 | 2.31 | 2.56 | 815,417 | |
09/11/2024 | 2.20 | 2.32 | 2.20 | 2.31 | 323,654 | |
09/10/2024 | 2.24 | 2.33 | 2.24 | 2.29 | 133,384 | |
09/09/2024 | 2.14 | 2.33 | 2.13 | 2.31 | 385,531 | |
09/06/2024 | 2.28 | 2.28 | 2.09 | 2.11 | 548,477 |
About Cardiff Oncology Stock history
Cardiff Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cardiff is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cardiff Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cardiff Oncology stock prices may prove useful in developing a viable investing in Cardiff Oncology
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 44.7 M | 46.9 M | |
Net Loss | -34.9 M | -36.6 M |
Cardiff Oncology Quarterly Net Working Capital |
|
Cardiff Oncology Stock Technical Analysis
Cardiff Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
All Next | Launch Module |
Cardiff Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cardiff Oncology's price direction in advance. Along with the technical and fundamental analysis of Cardiff Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cardiff to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0577 | |||
Jensen Alpha | 0.1951 | |||
Total Risk Alpha | (0.60) | |||
Sortino Ratio | 0.0311 | |||
Treynor Ratio | 0.2834 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Cardiff Stock analysis
When running Cardiff Oncology's price analysis, check to measure Cardiff Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardiff Oncology is operating at the current time. Most of Cardiff Oncology's value examination focuses on studying past and present price action to predict the probability of Cardiff Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardiff Oncology's price. Additionally, you may evaluate how the addition of Cardiff Oncology to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |